| |
| Price & Volume |
| Recent Price $ |
65.94 |
| 52 Week High $ |
117.82 |
| 52 Week Low $ |
47.63 |
| Average Vol (Mil) (RTMA) |
17.668 |
| Beta |
0.90 |
| Share Related Items |
| Market Cap. (Mil) $ |
1,531.708 |
| Shares Out (Mil) |
23.229 |
| Float (Mil) |
23.200 |
| Dividend Information |
| Yield % |
N/A |
| Annual Dividend |
0.00 |
| Payout Ratio (TTM) % |
0.00 |
| Financial Strength |
| Quick Ratio (MRQ) |
6.55 |
| Current Ratio (MRQ) |
6.86 |
| LT Debt/Equity (MRQ) |
58.21 |
| Total Debt/Equity (MRQ) |
58.21 |
| Valuation Ratios |
| Price/Earnings (TTM) |
40.17 |
| Price/Sales (TTM) |
5.77 |
| Price/Book (MRQ) |
3.56 |
| Price/Cash Flow (TTM) |
34.48 |
| Per Share Data |
| Earnings (TTM) $ |
1.64 |
| Sales (TTM) $ |
10.88 |
| Book Value (MRQ) $ |
18.53 |
| Cash Flow (TTM) $ |
1.82 |
| Cash (MRQ) $ |
10.01 |
| Mgmt Effectiveness |
| Return on Equity (TTM) |
12.40 |
| Return on Assets (TTM) |
6.31 |
| Return on Investment (TTM) |
6.70 |
| Profitability |
| Gross Margin (TTM) % |
89.34 |
| Operating Margin (TTM) % |
16.35 |
| Profit Margin (TTM) % |
15.19 |
Historical financial information is provided by Reuters. United Therapeutics Corporation makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information.
Mil = Millions RTMA = Rolling Three Month Average
TTM = Trailing Twelve Months MRQ = Most Recent Quarter
Asterisk (*) indicates numbers are derived from Earnings Announcements
Pricing and volume data as of Jan 6, 2009.
|
